Orphan designation: Human/murine chimeric monoclonal antibody against endoglin (carotuximab), Treatment of soft tissue sarcoma

Case Medical Research ◽

10.31525/cmr-1363a74 ◽

2019 ◽

Author(s):

Keyword(s):

Monoclonal Antibody ◽

Soft Tissue ◽

Soft Tissue Sarcoma ◽

Orphan Designation ◽

Chimeric Monoclonal Antibody

Download Full-text

Orphan designation: 4-oxo-4H-chromene-2-carboxylic acid (2-(2-4-(2-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)-ethyl)-phenyl-2H-tetrazol-5-yl)-4,5-dimethoxy-phenyl)-amide, Treatment of soft tissue sarcoma

Case Medical Research ◽

10.31525/cmr-27659a5 ◽

2020 ◽

Author(s):

Keyword(s):

Carboxylic Acid ◽

Soft Tissue ◽

Soft Tissue Sarcoma ◽

Orphan Designation

Download Full-text

Orphan designation: Olaratumab, Treatment of soft tissue sarcoma

Case Medical Research ◽

10.31525/cmr-26d9aeb ◽

2020 ◽

Author(s):

Keyword(s):

Soft Tissue ◽

Soft Tissue Sarcoma ◽

Orphan Designation

Download Full-text

Orphan designation: Vinorelbine tartrate, Treatment of soft tissue sarcoma

Case Medical Research ◽

10.31525/cmr-ea52cc ◽

2019 ◽

Author(s):

Keyword(s):

Soft Tissue ◽

Soft Tissue Sarcoma ◽

Orphan Designation

Download Full-text

Orphan designation: Chimeric monoclonal antibody to shiga toxin 1 and 2, Treatment of shiga-toxin-producing bacterial infection

Case Medical Research ◽

10.31525/cmr-ff5e19 ◽

2019 ◽

Author(s):

Keyword(s):

Monoclonal Antibody ◽

Bacterial Infection ◽

Shiga Toxin ◽

Orphan Designation ◽

Chimeric Monoclonal Antibody

Download Full-text

Orphan designation: Chimeric monoclonal antibody against GD2, Treatment of neuroblastoma

Case Medical Research ◽

10.31525/cmr-962c2f ◽

2019 ◽

Author(s):

Keyword(s):

Monoclonal Antibody ◽

Orphan Designation ◽

Chimeric Monoclonal Antibody

Download Full-text

A randomized phase Ib/II study evaluating the safety and efficacy of olaratumab (IMC-3G3), a human anti-platelet-derived growth factor α (PDGFRα) monoclonal antibody, with or without doxorubicin (Dox), in advanced soft tissue sarcoma (STS).

Journal of Clinical Oncology ◽

10.1200/jco.2015.33.15_suppl.10501 ◽

2015 ◽

Vol 33 (15_suppl) ◽

pp. 10501-10501 ◽

Author(s):

William D. Tap ◽

Robin L Jones ◽

Bartosz Chmielowski ◽

Anthony D. Elias ◽

Douglas Adkins ◽

...

Keyword(s):

Monoclonal Antibody ◽

Growth Factor ◽

Soft Tissue ◽

Soft Tissue Sarcoma ◽

Platelet Derived Growth Factor ◽

Advanced Soft Tissue Sarcoma ◽

Safety And Efficacy ◽

Phase Ib ◽

Download Full-text

Orphan designation: Recombinant chimeric monoclonal antibody against CD20, Treatment of chronic lymphocytic leukaemia

Case Medical Research ◽

10.31525/cmr-17cd5cc ◽

2019 ◽

Author(s):

Keyword(s):

Monoclonal Antibody ◽

Chronic Lymphocytic Leukaemia ◽

Lymphocytic Leukaemia ◽

Orphan Designation ◽

Chimeric Monoclonal Antibody

Download Full-text

Orphan designation: Vinorelbine tartrate, Treatment of soft tissue sarcoma

Case Medical Research ◽

10.31525/cmr-ea7c30 ◽

2019 ◽

Author(s):

Keyword(s):

Soft Tissue ◽

Soft Tissue Sarcoma ◽

Orphan Designation

Download Full-text

Clinical Study of PD-1 Monoclonal Antibody SHR-1210 and Apatinib in Advanced NSCLC, Soft Tissue Sarcoma, and Uterine Cancer

Case Medical Research ◽

10.31525/ct1-nct04239443 ◽

2020 ◽

Author(s):

Keyword(s):

Monoclonal Antibody ◽

Clinical Study ◽

Soft Tissue ◽

Soft Tissue Sarcoma ◽

Advanced Nsclc ◽

Download Full-text

A randomized phase 1b/2 study evaluating the safety and efficacy of doxorubicin (dox) with or without olaratumab (IMC-3G3), a human anti–platelet-derived growth factor &agr; (pdgfr&agr;) monoclonal antibody, in advanced soft tissue sarcoma (sts)

Annals of Oncology ◽

10.1093/annonc/mdw343.01 ◽

2016 ◽

Vol 27 ◽

pp. iv98 ◽

Author(s):

W. Tap ◽

R.L. Jones ◽

B. Chmielowski ◽

A.D. Elias ◽

D. Adkins ◽

...

Keyword(s):

Monoclonal Antibody ◽

Growth Factor ◽

Soft Tissue ◽

Soft Tissue Sarcoma ◽

Platelet Derived Growth Factor ◽

Advanced Soft Tissue Sarcoma ◽

Safety And Efficacy ◽

Download Full-text